Patents by Inventor Robert Brey

Robert Brey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11920869
    Abstract: An energy-moving device (EMD) transfers heat between a low-temperature-rated device (LTRD) and a high-temperature-rated device (HTRD), wherein the LTRD is thermally separated from the HTRD such that the LTRD is not stacked above the HTRD. A temperature-controlling device (TCD) actively transfers heat between the LTRD and the EMD. An air-moving device (AMD) generates an air stream for transferring heat from the EMD to ambient air. A controller receives temperature information about the ambient air, the LTRD, and the HTRD; determines when heat should be removed from the LTRD, when heat should be added to the LTRD, and when no heat needs to be transferred to or from the LTRD; and determines a first voltage for the TCD and a second voltage for the AMD based on the received temperature information. And a neural network updates the voltage values based on how effectively the voltage values have performed.
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: March 5, 2024
    Assignee: Continental Automotive Systems, Inc.
    Inventors: Robert Pozdal, Tony Asghari, Casey Szewc, Israel Cruz, Thomas Brey, James Snider
  • Patent number: 10293041
    Abstract: Stable immunogenic composition capable of eliciting a robust and durable immune response yielding a measurable increase in neutralizing antibodies at least 200 days post-administration, comprising at least one antigen consisting of a ribosome inactivating protein and at least one antigen comprising a toxin derived from bacterial spores. Method making and using a stable immunogenic composition capable of eliciting a stable immune response yielding a measurable increase in neutralizing antibodies at least 200 days post-administration, comprising providing an immunogenic composition comprising at least one antigen comprising a ribosome inactivating protein and at least one antigen comprising a toxin derived from bacterial spores and administering the immunogenic composition to an individual.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: May 21, 2019
    Assignee: Soligenix, Inc.
    Inventors: Robert Brey, Christopher Schaber
  • Publication number: 20170333544
    Abstract: Stable immunogenic composition capable of eliciting a robust and durable immune response yielding a measurable increase in neutralizing antibodies at least 200 days post-administration, comprising at least one antigen consisting of a ribosome inactivating protein and at least one antigen comprising a toxin derived from bacterial spores. Method making and using a stable immunogenic composition capable of eliciting a stable immune response yielding a measurable increase in neutralizing antibodies at least 200 days post-administration, comprising providing an immunogenic composition comprising at least one antigen comprising a ribosome inactivating protein and at least one antigen comprising a toxin derived from bacterial spores and administering the immunogenic composition to an individual.
    Type: Application
    Filed: July 9, 2015
    Publication date: November 23, 2017
    Inventors: Robert Brey, Christopher Schaber
  • Publication number: 20170007682
    Abstract: Stable immunogenic composition capable of eliciting a robust and durable immune response yielding a measurable increase in neutralizing antibodies at least 200 days post-administration, comprising at least one antigen consisting of a ribosome inactivating protein and at least one antigen comprising a toxin derived from bacterial spores. Method making and using a stable immunogenic composition capable of eliciting a stable immune response yielding a measurable increase in neutralizing antibodies at least 200 days post-administration, comprising providing an immunogenic composition comprising at least one antigen comprising a ribosome inactivating protein and at least one antigen comprising a toxin derived from bacterial spores and administering the immunogenic composition to an individual.
    Type: Application
    Filed: July 9, 2015
    Publication date: January 12, 2017
    Inventors: Robert Brey, Christopher Schaber
  • Publication number: 20130309273
    Abstract: The disclosure provides compositions relating to thermostable vaccines and methods of preparing same. Specifically, the disclosure provides for methods of preparing thermostable vaccines based on a recombinant ricin neurotoxin protein and uses of co-adjuvants to develop a composition capable of eliciting an immune response in a subject.
    Type: Application
    Filed: May 17, 2012
    Publication date: November 21, 2013
    Inventors: Kimberly Hassett, Pradyot Nandi, Robert Brey, John Carpenter, Theodore W. Randolph
  • Publication number: 20050070670
    Abstract: The present invention includes novel polyoxyethylene/polyoxypropylene block copolymers as well as methods for making the block copolymers. The block copolymers are high molecular weight molecules and are useful as general surfactants and display enhanced biological efficacy as vaccine adjuvants.
    Type: Application
    Filed: July 9, 2004
    Publication date: March 31, 2005
    Inventors: Mannarsamy Balasubramanian, Mark Newman, R. Emanuele, Carlos Rivera-Marrero, Charles Todd, Robert Brey
  • Patent number: 5029217
    Abstract: An apparatus and technique for enhancing the hearing capabilities of persons by providing a device which is a model of the desired hearing characteristic of the persons.
    Type: Grant
    Filed: April 3, 1989
    Date of Patent: July 2, 1991
    Assignees: Harold Antin, Mark Antin
    Inventors: Douglas M. Chabries, Robert Brey, Martin Robinette, Richard W. Christiansen, Gary R. Kenworthy